MedPath

The effect of Percutaneous embolization in patients with symptomatic liver hemangiomas

Phase 2
Recruiting
Conditions
iver symptomatic hemangioma.
Haemangioma, any site
D18.0
Registration Number
IRCT20130812014333N154
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
19
Inclusion Criteria

A giant hepatic hemangioma with clear margins
The number of platelets is more than 100,000
International Ratio Normalized less than 1/5

Exclusion Criteria

Patients with severe ascites
Improper position of the hemangioma
Patients with hepatic or renal impairment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ltrasound volume. Timepoint: At the beginning of the study and 6 months after the end of the study. Method of measurement: Using the GE-Logic S6 ultrasound device.;Largest diameter of ultrasond. Timepoint: At the beginning of the study and 6 months after the end of the study. Method of measurement: Using the GE-Logic S6 ultrasound device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath